Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study
Status:
Recruiting
Trial end date:
2022-02-09
Target enrollment:
Participant gender:
Summary
This is a 6 month study that will evaluate the efficacy of 5mg tofacitinib tablet taken twice
a day in patients with refractory myasthenia gravis. Twenty adult participants will receive a
four month treatment of tofacitinib followed by elution for one month.